| TRADING CENTER |
| Cancer Isn't Merck's Biggest Problem - MotleyFool.com | |
| The World's Best Dividend Stocks - MotleyFool.com | |
| 'Good' cholesterol less protective with diabetes - Reuters | |
| US FDA: unlikely Merck's Vytorin ups cancer risk - Reuters | |
| How to Make $1 Million - MotleyFool.com | |
| Pfizer Swings for the Fences - MotleyFool.com | |
| Some Incyte Into Why These Drugs Rock - MotleyFool.com | |
| Five Software Stocks to Watch in 2010 ($) - at TheStreet.com | |
| 2nd UPDATE: Centocor's $1.67 Billion Court Win Versus Abbott Upheld - Dow Jones | |
| UPDATE: Centocor's $1.67 Billion Court Win Versus Abbott Upheld - Dow Jones | |
| Centocor's $1.67 Billion Court Win Versus Abbott Upheld - Dow Jones | |
| 2009: The Year Pharma Learned to Love Itself - MotleyFool.com | |
| ABT Seeks Simcor Label Expansion - Analyst Blog - Zacks.com | |
| Meds Without Passports - MotleyFool.com | |
| Celgene Drug Meets Study Goal - Analyst Blog - Zacks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.70 | 0.00 / 0.00% | 14.13 |
| PFE | Pfizer Inc | 18.60 | 0.00 / 0.00% | 15.63 |
| NVS | Novartis AG | 54.84 | 0.00 / 0.00% | 15.40 |
| 2008 Revenue: | $29.5 B | Headquarters: Abbott Park, IL |
| Employees: | 69,000 | CEO: Miles D. White |
| Net Income: | $4.9 B | Industry: Pharmaceuticals |
| Market Cap: | $83.8 B | Website: www.abbott.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ABT | 54.15 | 0.00 / 0.00% | 54.15 | 0.00 | 0.00 | Profile Chart News |